Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD
08/26/24 • 14 min
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD.
Episode outline:
- Moving beyond lipid lowering to address residual inflammatory risk
- Novel anti-inflammatory targets for ASCVD
To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:
- CME-certified text module with animated pathophysiology video and faculty voice audio clips
- ClinicalThought commentaries
- Podcast episode 1, discussing residual risk associated with systemic inflammation and the role of cardiologists and nephrologists in mitigating risk in ASCVD and CKD
- Podcast episode 3, featuring faculty discussion of new and emerging therapies to target inflammatory risk in patients with ASCVD and CKD
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD.
Episode outline:
- Moving beyond lipid lowering to address residual inflammatory risk
- Novel anti-inflammatory targets for ASCVD
To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:
- CME-certified text module with animated pathophysiology video and faculty voice audio clips
- ClinicalThought commentaries
- Podcast episode 1, discussing residual risk associated with systemic inflammation and the role of cardiologists and nephrologists in mitigating risk in ASCVD and CKD
- Podcast episode 3, featuring faculty discussion of new and emerging therapies to target inflammatory risk in patients with ASCVD and CKD
Previous Episode
Navigating IgA Nephropathy: Insights From a Patient With Lived Experience
In this CCO Nephrology podcast episode, hear from Kelly Chen, a nephrology nurse practitioner and patient living with IgA nephropathy, as she discusses her experiences with Dr Pietro Canetta, Associate Professor of Medicine at Columbia University and expert in glomerular diseases.
Episode outline:
- Seeking and obtaining an IgAN diagnosis
- Patient self-advocacy
- Individualizing IgAN treatment plans
- Clinical trial involvement
- Burdens of IgAN: physical, emotional, social, and beyond
To learn more about IgA nephropathy, find more educational activities and resources with the links below:
Next Episode
Expert Discussions on Residual Systemic Inflammation in ASCVD and CKD
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore new and emerging strategies to target residual risk associated with systemic inflammation in patients with ASCVD and CKD.
Episode outline:
- The relationship among systemic inflammation, ASCVD, and CKD
- The role of cardiologists and nephrologists in screening and mitigating systemic inflammation
To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:
- CME-certified text module with animated pathophysiology video and faculty voice audio clips
- ClinicalThought commentaries
- Podcast episode 2, discussing novel therapeutic approaches to address residual inflammatory risks in patients with ASCVD and CKD
- Podcast episode 3, featuring faculty discussion of new and emerging therapies to target inflammatory risk in patients with ASCVD and CKD
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/cco-medical-specialties-podcast-642721/expert-discussions-moving-beyond-lipid-lowering-to-lower-risk-in-ascvd-85210100"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to expert discussions: moving beyond lipid lowering to lower risk in ascvd and ckd on goodpods" style="width: 225px" /> </a>
Copy